Reviva Pharmaceuticals Holdings, Inc.
RVPH
$1.87
-$0.45-19.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.90M | 2.35M | 2.42M | 1.60M | 1.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.03M | 6.07M | 6.54M | 6.28M | 8.46M |
| Operating Income | -4.03M | -6.07M | -6.54M | -6.28M | -8.46M |
| Income Before Tax | -4.01M | -6.05M | -6.43M | -6.25M | -8.37M |
| Income Tax Expenses | 2.80K | 8.00K | 5.20K | 4.70K | -- |
| Earnings from Continuing Operations | -4.01M | -6.05M | -6.43M | -6.26M | -8.37M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.01M | -6.05M | -6.43M | -6.26M | -8.37M |
| EBIT | -4.03M | -6.07M | -6.54M | -6.28M | -8.46M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1.10 | -2.43 | -2.64 | -3.27 | -4.95 |
| Normalized Basic EPS | -0.69 | -1.52 | -1.65 | -2.04 | -3.09 |
| EPS Diluted | -1.10 | -2.43 | -2.64 | -3.27 | -4.95 |
| Normalized Diluted EPS | -0.69 | -1.52 | -1.65 | -2.04 | -3.09 |
| Average Basic Shares Outstanding | 3.63M | 2.49M | 2.43M | 1.92M | 1.69M |
| Average Diluted Shares Outstanding | 3.63M | 2.49M | 2.43M | 1.92M | 1.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |